X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Cell-Energy Activity In Organs, Tissues By New MRI Method

    Cell-Energy Activity In Organs, Tissues By New MRI Method

    GE Healthcare Launches Viral Vector Based Gene Therapy Manufacturing

    Australia Sepsis Study To Aid In New Antibiotic Discovery

    FDA Grants Fast Track Designation to CERC-002 for Treatment of Hospitalized Patients with COVID-19

    COVID-19 Hospitalisation Dips Using Monoclonal Antibodies

    Regulatory Actions Needed For Gaps In Cancer Drug Info

    A Fund Boost For World-First Nervous System Transplant Study

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Cell-Energy Activity In Organs, Tissues By New MRI Method

    Cell-Energy Activity In Organs, Tissues By New MRI Method

    GE Healthcare Launches Viral Vector Based Gene Therapy Manufacturing

    Australia Sepsis Study To Aid In New Antibiotic Discovery

    FDA Grants Fast Track Designation to CERC-002 for Treatment of Hospitalized Patients with COVID-19

    COVID-19 Hospitalisation Dips Using Monoclonal Antibodies

    Regulatory Actions Needed For Gaps In Cancer Drug Info

    A Fund Boost For World-First Nervous System Transplant Study

    New Delivery Path Brings To Light Efficacy of Immunotherapy

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

Pharma Supply Chain Present Danger As Drug Shortages Rise

Content Team by Content Team
8th April 2023
in Facilities & Operation, News

Drug shortages endanger national security as well as public health. This is the conclusion of a new report from the United States Senate’s Homeland Security Committee.

As per the report, medicine shortages reached a five-year high of 295 in 2022, with more than 15 vital products in short supply for over a decade.

There were shortages of life-saving prescriptions such as cancer therapies and emergency department pharmaceuticals, as well as basic medicines such as children’s fever controllers and antibiotics, during the 2022 cold and flu season.

The report highlighted the following main concerns in supply chains and regulation:

  • The report portrayed the geographic concentration of supply for vital medications and commodities, as well as restricted domestic manufacturing capabilities, as a national security issue.
  • The FDA cannot make use of unorganized data provided by drugmakers since it will not be used in predictive modelling.
  • Both the government and businesses lack end-to-end transparency in pharmaceutical supply networks.
  • The FDA lacks the authority to order recalls of most pharmaceuticals.

Geographically, the majority of medication and ingredient manufacturers are concentrated in just two countries: China and India.

By 2015, China had 445 active pharmaceutical ingredients (API) factories, a twofold increase over the previous five years. Meanwhile, according to statistics cited by the Senate committee from the nonprofit U.S. Pharmacopeia, India accounted for the bulk of FDA-approved API facilities as of 2021.

The COVID-19 pandemic has worsened shortages by raising demand for various drugs while also putting strain on pharmaceutical supply networks. Yet, many of the root causes of supply shortages may be traced back to pre-pandemic years.

Among them are financial incentives for medication production. According to the study, while the prices per medicine are typically fairly cheap, they necessitate sophisticated production methods and create obstacles to entry for would-be drugmakers. Industry consolidation has also had an impact on supply resilience.

Many recommendations were made in the report to bolster drug supplies and supply chains, including:

  • Investments in enhanced manufacturing capacities for key medications through public-private partnerships, with the prospect for long-term government contracts for generics providers.
  • Routine government supply chain risk evaluations.
  • Creating a materials database that can be used to determine risk by the FDA.
  • Give the FDA obligatory recall authority over all pharmaceutical items.

Previous Post

World Cell & Gene Therapy Supply Chain To Hit $3.12b By 2031

Next Post

The Ever-Thriving Pharma Cold Chain Logistics In Europe

Related Posts

Facilities & Operation

The Ever-Thriving Pharma Cold Chain Logistics In Europe

8th April 2023
Facilities & Operation

World Cell & Gene Therapy Supply Chain To Hit $3.12b By 2031

8th April 2023
Cell-Energy Activity In Organs, Tissues By New MRI Method
News

Cell-Energy Activity In Organs, Tissues By New MRI Method

5th April 2023
TrakCel and WindMIL Therapeutics partner on cell therapy supply chain management and orchestration platform
News

Seamlessness In Patient Engagement Through eConsent Trial

5th April 2023
GE Healthcare Launches Viral Vector Based Gene Therapy Manufacturing
Drug Development

Australia Sepsis Study To Aid In New Antibiotic Discovery

5th April 2023
FDA Grants Fast Track Designation to CERC-002 for Treatment of Hospitalized Patients with COVID-19
News

COVID-19 Hospitalisation Dips Using Monoclonal Antibodies

5th April 2023
Next Post

The Ever-Thriving Pharma Cold Chain Logistics In Europe

Latest News

Facilities & Operation

The Ever-Thriving Pharma Cold Chain Logistics In Europe

8th April 2023
Facilities & Operation

Pharma Supply Chain Present Danger As Drug Shortages Rise

8th April 2023
Facilities & Operation

World Cell & Gene Therapy Supply Chain To Hit $3.12b By 2031

8th April 2023
Cell-Energy Activity In Organs, Tissues By New MRI Method
News

Cell-Energy Activity In Organs, Tissues By New MRI Method

5th April 2023
TrakCel and WindMIL Therapeutics partner on cell therapy supply chain management and orchestration platform
News

Seamlessness In Patient Engagement Through eConsent Trial

5th April 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In